CytomX Therapeutics (CTMX) Construction in Progress (2017 - 2023)
CytomX Therapeutics (CTMX) posted Construction in Progress of $368000.0 for Q4 2023, down 47.8% on a QoQ basis from $705000.0 in Q4 2022, and down 47.8% year-over-year from $705000.0 in Q4 2022.
CytomX Therapeutics (CTMX) Construction in Progress (2017 - 2023) Analysis & Trends
CytomX Therapeutics' Construction in Progress history runs 7 years deep, the most recent figure standing at $368000.0 for Q4 2023.
- Quarterly Construction in Progress fell 47.8% year-over-year to $368000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $368000.0 (down 47.8% YoY) and the FY2023 annual result came in at $368000.0, down 47.8% from the prior year.
- Construction in Progress was $368000.0 for Q4 2023 at CytomX Therapeutics, down from $705000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $705000.0 in Q4 2022 and bottomed at $236000.0 in Q4 2019.
- A 5-year average of $373800.0 and a median of $308000.0 in 2021 frame the typical range for Construction in Progress.
- Annual changes were most pronounced in 2019 — Construction in Progress tumbled 69.94% — and 2022, when it surged 128.9%.
- CytomX Therapeutics' Construction in Progress stood at $236000.0 in 2019, then gained by 6.78% to $252000.0 in 2020, then increased by 22.22% to $308000.0 in 2021, then jumped by 128.9% to $705000.0 in 2022, then sank by 47.8% to $368000.0 in 2023.
- Business Quant data shows CTMX's Construction in Progress at $368000.0 in Q4 2023, $705000.0 in Q4 2022, and $308000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 137.45 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 368,000.00 |
| Dec 31, 2022 | 705,000.00 |
| Dec 31, 2021 | 308,000.00 |
| Dec 31, 2020 | 252,000.00 |
| Dec 31, 2019 | 236,000.00 |
| Dec 31, 2018 | 785,000.00 |
| Dec 31, 2017 | 23,000.00 |